Back to search

Article

Macrophage Antigen Presentation Is Unleashed by Pan-RAS Inhibition to Promote Antitumor Immunity

2026-02-02

Abstract excerpt

Pan-RAS inhibitors have emerged as potent targeted therapies designed to suppress oncogenic signaling in RAS-mutant tumors. However, whether these inhibitors possess therapeutic utility beyond tumors with intrinsic RAS dependency remains unclear. Here we show that the clinical-stage pan-RAS(ON) inhibitor RMC-6236 (Daraxonrasib) induces robust regression of NRAS–wild-type B16 tumors in immunocompetent mice, a respo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fc114bf8-7d44-51b9-9f2d-678d456739b8
DOI
10.64898/2026.01.30.702886
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Macrophage Antigen Presentation Is Unleashed by Pan-RAS Inhibition to Promote Antitumor ImmunityDOI 10.64898/2026.01.30.702886
Select a neighboring publication to make it the new centre.